AI for Drug Discovery

Using artificial intelligence to help accelerate drug discovery, screening, development, and related pharmaceutical research.

Lux logo LUX TAKE:

After many years of development and interest, major pharmaceutical companies are making more significant investments in AI and forging more and deeper relationships with startups. COVID-19 is also bringing these tools into the spotlight, as they are becoming critical in developing treatments and vaccines. The innovations coming out of these processes are being augmented and finding their way into ...


Lux Take last updated on April 24, 2020
Data last updated on January 21, 2021

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent AI for drug discovery developments.

New Lux Content

Technology Landscape: Key players in materials informatics (December 24, 2020)

Digital's 2020 Year in Review: Innovation Transformation (December 22, 2020)

New Patents


Computing...

New Investment Rounds


Computing...

Related companies Schrödinger, Deep Genomics, InsideDNA, Numerate, Atomwise, Deep 6 AI, Recursion Pharmaceuticals , Berg, Insilico Medicine, XtalPi, NuMedii, OWKIN, twoXAR, Cyclica, BioXcel Therapeutics, Verge Genomics, Exscientia, Globavir Biosciences, Engine Biosciences, Healx, Lantern Pharma, Standigm, Bioage Labs, e-Therapeutics, GTN, Mind the Byte, Quantitative Medicine, Linguamatics, BenevolentAI, Cyrus Biotechnology, Zymol

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978